News

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for QINLOCK® (ripretinib)
Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Deciphera ...
Clinical Trials Arena on MSN2d
Enrolment concludes in Phase III trial of Dizal’s sunvozertinib for NSCLC
The trial is being carried out in 16 nations and regions, including Asia, North America, Europe, and South America.
ahajournals.org5d
Protein Kinase A Phosphorylation of the Ryanodine Receptor Does Not Affect Calcium Sparks in Mouse Ventricular Myocytes
From the Department of Physiology and Cardiovascular Institute (Y.L., G.A.M., D.M.B.), Loyola University Chicago, Stritch School of Medicine, Maywood, Ill; Department ...
Chronic Lymphocytic Leukemia Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
DelveInsight’s, “Chronic Lymphocytic Leukemia Pipeline Insight 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia (CLL) pipeline ...
MedPage Today6d
BTK Inhibitors for Multiple Sclerosis
Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...